Skip to content
Investing

Saab's Order Intake More Than Triples to SEK 65.8bn as Defence Demand Accelerates

Saab booked SEK 65.8bn of orders in the third quarter, more than triple a year earlier, led by Gripen E fighters for Ukraine. Organic sales grew 30.6% and operational cash flow jumped to SEK 6.8bn.

Micael Johansson, President and CEO of Saab
Saab

Saab took in SEK 65.8bn of new orders in the third quarter, more than three times the SEK 20.9bn of a year earlier, as demand for fighters, surveillance aircraft and naval systems turned into signed contracts. The Swedish defence group also beat expectations on sales and operating profit, and its operational cash flow jumped to SEK 6.8bn from almost nothing a year earlier.

Third quarter 2026

  • SEK 65.8bn of orders, against SEK 20.9bn a year earlier
  • 30.6% organic sales growth
  • SEK 6.8bn operational cash flow, up from SEK 142m

Three Contracts Drove the Order Surge

The quarter's bookings were dominated by three large contracts. The biggest was SEK 24.6bn for 16 Gripen E fighters for Ukraine, with spare parts and support equipment. The contract was signed with Sweden's defence procurement agency FMV on 30 June, and the aircraft are scheduled for delivery in 2029 and 2030. On its own it accounted for more than a third of the quarter's orders.

Saab also booked SEK 10.1bn for two GlobalEye airborne surveillance aircraft for an undisclosed customer, due for delivery in 2030, and SEK 8.7bn for systems for German frigates.

The order backlog reached SEK 364.2bn at the end of September, according to figures reported by Finwire and AeroTime. That is about 80% higher than the SEK 202.4bn of a year earlier and up from SEK 274.5bn at the start of the year. With quarterly sales of about SEK 20.6bn, the backlog now covers several years of work, though much of the Ukrainian contract will only turn into revenue towards the end of the decade.

Saab's future uncrewed air combat system concept (A3). Saab
Saab's future uncrewed air combat system concept (A3). Saab

Sales, Profit and Margin

Sales rose to SEK 20,553m from SEK 15,871m. Organic growth, which strips out acquisitions and currency effects, was 30.6%, up from 18.3% a year earlier.

Operating income (EBIT) grew 42% to SEK 1,945m. The EBIT margin widened to 9.5% from 8.7%, showing that the company is converting higher volumes into higher profitability. Net income was SEK 1,432m and earnings per share rose to SEK 2.57 from SEK 1.77.

The figures came in above market forecasts. According to FactSet consensus cited by Finwire, analysts had expected sales of about SEK 19,972m and EBIT of about SEK 1,842m. Saab beat both, by roughly 3% and 6%.

SEK millionQ3 2026Q3 2025Change
Order bookings65,82520,861+216%
Sales20,55315,871+30%
EBIT1,9451,374+42%
EBIT margin9.5%8.7%+0.8 pts
Operational cash flow6,785142

Cash Flow Finally Follows the Orders

For investors, the most striking change may be in cash. Operational cash flow was SEK 6,785m, against SEK 142m in the same quarter of 2025. Saab's results summary does not break down the jump, but large defence contracts often come with advance payments that lift cash flow around the time they are signed.

Net liquidity rose to SEK 8,679m, from SEK 3,989m at the end of 2025. A stronger balance sheet gives Saab room to keep investing in production capacity, which it needs to deliver on a backlog of this size.

Chief executive Micael Johansson described a quarter of high organic growth, significantly higher cash flow and strong orders, pointing to the Gripen, GlobalEye and German frigate contracts as signs of growing customer demand. He said Saab would keep investing in future capabilities and expanding capacity, and that its backlog and programme progress left it well placed for continued growth.

What stands out

  • Orders more than tripled, led by Gripen E for Ukraine, GlobalEye and German frigate systems
  • Sales and EBIT both beat FactSet consensus
  • EBIT margin rose to 9.5%, so growth is lifting profitability
  • Operational cash flow of SEK 6.8bn compares with almost nothing a year earlier
  • The backlog stands at about SEK 364bn

What to Watch Next

The challenge now is execution. A backlog of this size depends on supply chains, staffing and new capacity coming on stream on time, and large aircraft programmes such as Gripen and GlobalEye run for years. Margins on long contracts can move as costs change.

There is also a timing gap. A large share of the new orders will be delivered from 2029, so revenue growth in the coming quarters will rely on contracts already in production.

For investors comparing European defence groups, the quarter offers a clear test case. Higher government budgets only help shareholders once they become signed contracts, deliveries and cash. On all three measures, Saab's third quarter showed progress: orders were signed, sales grew faster and the cash arrived.

Sources

Related stories

Markets

Volvo Truck Orders Jump 26% and Margins Recover, but Sales Fall Short of Forecasts

Volvo's truck orders rose 26% in the third quarter and its adjusted margin rose to 12.3%, with profit of SEK 14.7bn in line with forecasts, but sales of SEK 119.5bn fell 3.7%…

Investing

Europe's Big Banks Beat Forecasts: What BNP, Deutsche Bank, Santander and UBS Signal

BNP Paribas lifted profit 14 percent to €3.46 billion and Deutsche Bank and Santander beat forecasts, but Santander's 4.2 percent drop on Brazil shows how much investors already…

Investing

JPMorgan Misses as Bond Trading Slows While Goldman and Citi Shine

JPMorgan earned $5.57 a share in the third quarter, short of the $5.93 expected, as bond trading slowed. Goldman Sachs, Citigroup and Wells Fargo all beat forecasts.

Business

Ericsson Shares Jump 10% as Sales Rise 6% Despite a Flat Radio Market

Ericsson's third-quarter sales rose 6 percent to SEK 59.5 billion with 7 percent organic growth, sending the shares up about 10 percent in Stockholm despite a warning on margins…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…